Eris Lifesciences Limited has announced an upcoming conference call for analysts and investors. This call is scheduled to take place on Friday, February 13, 2026, at 05:30 PM IST. The purpose of this conference call is to discuss the standalone and consolidated unaudited financial results for the quarter and nine months ended December 31, 2025. This information follows a previous intimation regarding the Board of Directors meeting to consider and approve these financial results, which was dated February 06, 2026. Details for joining the call are available on the Company’s website and were attached to the announcement. Interested participants can pre-register for the Zoom call via a provided link. The company looks forward to the participation of analysts and investors.
